CHITI, ARTURO
 Distribuzione geografica
Continente #
NA - Nord America 5.971
AS - Asia 5.794
EU - Europa 5.479
SA - Sud America 964
Continente sconosciuto - Info sul continente non disponibili 705
AF - Africa 138
OC - Oceania 43
Totale 19.094
Nazione #
US - Stati Uniti d'America 5.634
RU - Federazione Russa 2.993
SG - Singapore 2.211
CN - Cina 1.641
IT - Italia 1.317
BR - Brasile 789
HK - Hong Kong 615
BD - Bangladesh 394
VN - Vietnam 386
FR - Francia 236
DE - Germania 194
GB - Regno Unito 185
CA - Canada 156
IN - India 125
NL - Olanda 103
FI - Finlandia 98
MX - Messico 86
SE - Svezia 73
ES - Italia 65
JP - Giappone 65
AT - Austria 55
AR - Argentina 53
ZA - Sudafrica 44
AU - Australia 41
PL - Polonia 41
TR - Turchia 38
ID - Indonesia 32
PK - Pakistan 32
MA - Marocco 31
IQ - Iraq 30
MY - Malesia 29
EC - Ecuador 28
SA - Arabia Saudita 28
AE - Emirati Arabi Uniti 23
PH - Filippine 23
CO - Colombia 22
JM - Giamaica 22
LT - Lituania 21
MD - Moldavia 20
VE - Venezuela 20
CL - Cile 19
UZ - Uzbekistan 19
CR - Costa Rica 17
EG - Egitto 16
TH - Thailandia 15
PY - Paraguay 14
UA - Ucraina 14
DZ - Algeria 13
JO - Giordania 12
NI - Nicaragua 11
TN - Tunisia 11
NP - Nepal 10
DK - Danimarca 9
IL - Israele 9
TW - Taiwan 9
HN - Honduras 8
BE - Belgio 7
KE - Kenya 7
KR - Corea 7
PE - Perù 7
BO - Bolivia 6
CH - Svizzera 5
GE - Georgia 5
GT - Guatemala 5
HR - Croazia 5
IE - Irlanda 5
PR - Porto Rico 5
PT - Portogallo 5
UY - Uruguay 5
BB - Barbados 4
BG - Bulgaria 4
EE - Estonia 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
AZ - Azerbaigian 3
BZ - Belize 3
CG - Congo 3
KH - Cambogia 3
KZ - Kazakistan 3
LB - Libano 3
OM - Oman 3
QA - Qatar 3
RO - Romania 3
SC - Seychelles 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
AG - Antigua e Barbuda 2
AL - Albania 2
BH - Bahrain 2
CU - Cuba 2
CW - ???statistics.table.value.countryCode.CW??? 2
CY - Cipro 2
CZ - Repubblica Ceca 2
DM - Dominica 2
DO - Repubblica Dominicana 2
GR - Grecia 2
HU - Ungheria 2
IR - Iran 2
KG - Kirghizistan 2
LK - Sri Lanka 2
Totale 18.363
Città #
Singapore 1.204
San Jose 850
Ashburn 716
Moscow 664
Hong Kong 596
Dallas 552
Council Bluffs 316
Milan 312
Shanghai 299
Beijing 263
New York 259
Hefei 228
Lauterbourg 192
Phoenix 174
Los Angeles 171
Santa Clara 149
Rome 129
Ho Chi Minh City 126
Hanoi 90
São Paulo 62
Orem 61
Seattle 59
Nuremberg 53
Munich 52
Boardman 51
Montreal 48
Denver 47
Chennai 46
Washington 46
Atlanta 45
Tokyo 43
Brooklyn 41
London 40
Helsinki 39
Mexico City 39
Naples 39
Turku 39
Buffalo 38
Chicago 36
Bologna 34
Amsterdam 33
Toronto 33
Warsaw 33
Frankfurt am Main 31
Johannesburg 31
Houston 25
Poplar 25
Stockholm 25
Guangzhou 24
San Francisco 24
The Dalles 23
Belo Horizonte 22
Brescia 22
Florence 22
Las Vegas 22
Canberra 20
Lappeenranta 20
Newark 20
Rio de Janeiro 20
Genoa 19
Manchester 19
Turin 19
Valencia 19
Vienna 19
Hangzhou 18
Memphis 18
Ankara 17
Da Nang 17
Mumbai 17
Princeton 17
Tashkent 17
Assago 16
Cesano Boscone 16
Charlotte 16
Miami 16
Omaha 16
Shenzhen 16
Bari 15
Haiphong 15
Lawrence 15
Sydney 15
Abu Dhabi 14
Biên Hòa 14
Philadelphia 14
Tianjin 14
Boston 13
Falkenstein 13
Figino 13
Kingston 13
Quito 13
Kuala Lumpur 12
Querétaro 12
Santiago 12
Amman 11
City of London 11
Cleveland 11
Queens 11
San José 11
Wuhan 11
Bang Kruai 10
Totale 9.328
Nome #
Contrast-Enhanced Mammography versus Breast Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis 321
Allogeneic Stem Cell Transplantation (Allo-SCT) after Treatment with Programmed Cell Death-1 (PD-1) Checkpoint Inhibitors for Relapsed/Refractory Classic Hodgkin Lymphoma (R/R cHL) Is Associated with an Unprecedented Low Relapse Rate 313
Case Report: A Challenging Localization of a Pulmonary Ectopic ACTH-Secreting Tumor in a Patient With Severe Cushing’s Syndrome 243
[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration 194
The Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Assessment of Local Recurrence and Distant Metastases in Patients with Biochemical Recurrence of Prostate Cancer After Definitive Treatment: A Systematic Review and Meta-analysis 183
Early regression index (ERI) on MR images as response predictor in esophageal cancer treated with neoadjuvant chemo-radiotherapy: interim analysis of the prospective ESCAPE trial 179
EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems 170
A Multimodal Protocol Combining 99mTc-Tilmanocept with Indocyanine Green Fluorescence Lympho-Angiography for Sentinel Lymph Node Biopsy in Early-Stage Oral Cancer: A Case Series. 165
[F-18]FDG PET/CT in non-union: improving the diagnostic performances by using both PET and CT criteria 161
Complete remission of follicular lymphoma after SARS-CoV-2 infection: from the "flare phenomenon" to the "abscopal effect" 157
[18F]FDG-PET/CT Texture Analysis in “Hot” Thyroid Nodules: Results of the validation Cohort 156
Single-Center Retrospective Study Comparing Double Vein Embolization via a Trans-Jugular Approach with Liver Venous Deprivation via a Trans-Hepatic Approach 155
Match Point: Nuclear Medicine Imaging for Recurrent Thyroid Cancer in TENIS Syndrome—Systematic Review and Meta-Analysis 154
Deep learning in Nuclear Medicine—focus on CNN-based approaches for PET/CT and PET/MR: where do we stand? 143
Challenging the significance of SUV-based parameters in a large-scale retrospective study on lung lesions 142
Time for action: actinium-225 PSMA-targeted alpha therapy for metastatic prostate cancer – a systematic review and meta-analysis 140
Data-Driven Motion Correction of 11C-Methionine PET Images on a Cohort of Pediatric Patients With Brain Tumor in a PET/MRI Study 140
Prevention of Orbitopathy by Oral or Intravenous Steroid Prophylaxis in Short Duration Graves' Disease Patients Undergoing Radioiodine Ablation: A Prospective Randomized Control Trial Study 137
[18F]FDG PET/CT in Large Vessel Vasculitis: The Impact of Expertise and Confounders on Image Analysis 132
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients 132
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial 131
Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study 130
Predictors of PSMA PET Positivity: Analysis in a Selected Cohort of Biochemical Recurrence Prostate Cancer Patients after Radical Prostatectomy 129
Preoperative assessment of lymph nodal metastases with [68Ga]Ga-DOTATOC PET radiomics for improved surgical planning in well-differentiated pancreatic neuroendocrine tumours 128
Prognostic Value of Metabolic Imaging Data of 11C-choline PET/CT in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma 125
Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study 124
Cutting back on overdiagnosis – Occam’s Razor and unspecific bone uptakes in PSMA PET 122
Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters 119
Random forest analysis to predict Disease-Free Survival using FDG-PET and CT in Lung Cancer 119
Malignant pleural effusion (MPE) characterized with 11C-Methionine PET/CT before and after talc pleurodesis: interim evaluation of a prospective clinical trial 119
A Comprehensive Systematic Review and Meta-analysis of the Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Diagnosis and Primary Staging before Definitive Treatment 118
Imaging in Gastroparesis: Exploring Innovative Diagnostic Approaches, Symptoms, and Treatment 117
PSMA PET in brain metastases: navigating diagnostic challenges– a thorough exploration 115
Novel Radiopharmaceuticals and Future of Theranostics in Genitourinary Cancers 115
The Challenge of External Generalisability: Insights from the Bicentric Validation of a [68Ga]Ga-PSMA-11 PET Based Radiomics Signature for Primary Prostate Cancer Characterisation Using Histopathology as Reference 114
A virtual biopsy of liver parenchyma to predict the outcome of liver resection 114
Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions 111
External Validation of Nomograms for the Identification of Pelvic Nodal Dissection Candidates Among Prostate Cancer Patients with Negative Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography 110
Smaller is better? Compact vs. Conventional gamma camera for sentinel lymph node localization in patients with breast cancer 110
Virtual Biopsy for Diagnosis of Chemotherapy-Associated Liver Injuries and Steatohepatitis: A Combined Radiomic and Clinical Model in Patients with Colorectal Liver Metastases 109
Systematic Review and Metanalysis on the Role of Prostate-Specific Membrane Antigen Positron Emission Tomography/Magnetic Resonance Imaging for Intraprostatic Tumour Assessment 109
Radioembolization for Hepatocellular Carcinoma: a Comparison on Dual-phase Cone-beam CT, Contrast-enhanced CT (CECT) and 99mTc-macroaggregated albumin-SPECT/CT in predicting final distribution volumes and dosimetry of the post-embolization 90Y PET/CT 109
Senna intoxication as a cause of extrapontine myelinolysis mimicking rapidly progressive dementia: a case description 109
Imaging-Based Prediction of Molecular Therapy Targets in NSCLC by Radiogenomics and AI Approaches: A Systematic Review 108
Advanced Imaging Supports the Mechanistic Role of Autoimmunity and Plaque Rupture in COVID-19 Heart Involvement 108
Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience 108
[18F]FDG PET/MRI vs sentinel node biopsy for axillary staging of early breast cancer patients. A prospective single-arm trial 107
The diagnostic and prognostic value of tau-PET in amnestic MCI with different FDG-PET subtypes 106
Baseline circulating tumour DNA and interim PET predict response in relapsed/refractory classical Hodgkin lymphoma 105
ALBI grade for outcome prediction in patients affected by hepatocellular carcinoma treated with transarterial radioembolization 104
48P The relationship among bowel FDG-PET uptake, pathological complete response, and the influence of eating and exercise habits in breast cancer patients undergoing neoadjuvant chemotherapy 103
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 103
Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomas 100
Radioguided Surgery for Prostate Cancer 99
Baseline Radiomic CT Features Differentiate Mediastinal Masses As Thymic Neoplasms Or Lymphomas 98
A reflection on journal rankings 98
Absorbed dose from daily routine practice in an 18F-FDG producing radiopharmacy 96
Mapping brain metabolism, connectivity and neurotransmitters topography in early and late onset dementia with lewy bodies 96
The five “W”s and “How” of Targeted Alpha Therapy: Why? Who? What? Where? When? and How? 95
Correction: Radioembolization for Hepatocellular Carcinoma: a Comparison on Dual-phase Cone-beam CT, Contrast-enhanced CT (CECT) and 99mTc-macroaggregated albumin-SPECT/CT in predicting final distribution volumes and dosimetry of the post-embolization 90Y PET/CT 95
[18F]FDG PET/MRI in Endometrial Cancer: Prospective Evaluation of Preoperative Staging, Molecular Characterization and Prognostic Assessment 93
State-of-the-art of FAPI-PET imaging: a systematic review and meta-analysis 93
Advancing EJNMMI: continuing success and next developments 92
Baseline FDG-PET/CT Radiomics to Predict Outcome in Lung Cancer Patients Treated with Surgery 90
I-131/I-123-Metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging 89
New Mitral Regurgitation Unveiling Infective Endocarditis in an Adolescent With Mitral Valve Prolapse 88
68GA-PSMA PET/CT FOR PRIMARY DIAGNOSIS OF PROSTATE CANCER IN MEN WITH CONTRAINDICATIONS TO OR NEGATIVE MRI: A PROSPECTIVE OBSERVATIONAL STUDY 88
18F-FDG PET and CT scan in the pre-operative evaluation of colorectal liver metastases treated with chemotherapy 87
Functional Investigation of the Tumoural Heterogeneity of Intrahepatic Cholangiocarcinoma by In Vivo PET-CT Navigation: A Proof-of-Concept Study 86
Identifying critical steps towards improved access to innovation in cancer care: a European CanCer Organisation position paper 85
Individual cerebral metabolic deficits in Alzheimer's disease and amnestic mild cognitive impairment: an FDG PET study 84
Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis 83
Biological characterization of renal masses using immuno-PET 82
Towards clinical application of image mining: a systematic review on artificial intelligence and radiomics 82
The role of preoperative [11C]methionine PET in defining tumor-related epilepsy and predicting short-term postoperative seizure control in temporal lobe low-grade gliomas 82
Imaging of neuroendocrine tumours with gamma-emitting radiopharmaceuticals 80
Radiomics of Liver Metastases: A Systematic Review 80
Perceived risk and decision-making: navigating uncertainty in clinical practice 79
PET/CT-based radiomics of mass-forming intrahepatic cholangiocarcinoma improves prediction of pathology data and survival 79
Ga-68-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational Study 78
Application of Convolutional Neural Networks is promising in the definition of T-stage in lung cancer 78
Convolutional Neural Networks Promising in Lung Cancer T-Parameter Assessment on Baseline FDG-PET/CT 77
The Role of PET Imaging in the Differential Diagnosis between Radiation Necrosis and Recurrent Disease in Irradiated Adult-Type Diffuse Gliomas: A Systematic Review 76
The potential role of osteoporosis in unspecific [18F]PSMA-1007 bone uptake 76
Comprehensive one-day management of prostate cancer patients: PRO-FAST single-fraction ablative, urethral-sparing, HDR-like, robotic SBRT 75
Role of 11C Methionine Positron Emission Tomography (11CMETPET) for Surgery and Radiation Therapy Planning in Newly Diagnosed Glioblastoma Patients Enrolled into a Phase II Clinical Study 75
Enhancing NSCLC Histological Subtype Classification: A Federated Learning Approach Using Triplet Loss 75
Radiomics and gene expression profile to characterise the disease and predict outcome in patients with lung cancer 74
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study 74
Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study 73
C-11-Methionine uptake in secondary brain epilepsy 73
Radiomics of Intrahepatic Cholangiocarcinoma and Peritumoral Tissue Predicts Postoperative Survival: Development of a CT-Based Clinical-Radiomic Model 72
Hybrid PET/MRI in Infection and Inflammation: An Update About the Latest Available Literature Evidence 72
Vasculitis changes in COVID-19 survivors with persistent symptoms: an [18F]FDG-PET/CT study 71
Hodgkin lymphoma and imaging in the era of anti-PD-1/PD-L1 therapy 71
Intrahepatic cholangiocellular carcinoma with radiological enhancement patterns mimicking hepatocellular carcinoma 71
EANM/EARL FDG-PET/CT accreditation - summary results from the first 150 accredited imaging sites 71
Extended nodal radiotherapy for prostate cancer relapse guided with [11C]-choline PET/CT: ten-year results in patients enrolled in a prospective trial 71
Myocardial involvement in systemic sclerosis 71
The complementary role of PSMA expression and [18F]FDG PET/CT in predicting thyroid cancer outcome: from black and white to shades of gray, in the era of precision oncology 71
Totale 11.119
Categoria #
all - tutte 89.724
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.724


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225 0 0 0 5 0 0 0 0 0 0 0 0
2022/2023466 34 16 7 0 0 5 2 6 8 52 324 12
2023/20241.042 16 78 110 70 81 164 63 119 61 76 54 150
2024/20253.042 296 93 38 94 157 297 347 269 522 431 252 246
2025/202611.840 798 751 668 1.368 954 410 1.257 819 2.854 741 539 681
2026/20272.685 672 1.065 890 58 0 0 0 0 0 0 0 0
Totale 19.094